Novel Laboratories Inc. d.b.a Lupin recalls
Novel Laboratories Inc. d.b.a Lupin has 1 recall on record with the FDA and USDA, the earliest in 2021 and the latest reported on 25 Aug 2021. The most frequent reason is potency & assay.
Total recalls1since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 25 Aug 2021
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why novel laboratories inc. d.b.a lupin is recalled
Product types
By year
All novel laboratories inc. d.b.a lupin recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | GaviLyteTM - C PEG-3350 and Electrolytes for Oral Solution recalledGavilyte - C | Novel Laboratories Inc. d.b.a Lupin | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.